A study to assess the effects of Apremilast and Methotrexate in the treatment of patients with psoriasis
Not Applicable
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2019/01/017362
- Lead Sponsor
- RATHIPRIYADHARSHINI R
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Those With chronic plaque psoriasis involving >10%BSA
Those who sign the written consent form prior to participation in the study
Exclusion Criteria
pregnancy
lactation
abnormalities in LFT,RFT,CBC
hypertension and diabetes
active tuberculosis/ HIV infection
Hypersensitivity to the drugs
Those on immunosuppresive medications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method